Home Tags Novartis

Tag: Novartis

Elizabeth Warren and Bernie Sanders were two of five senators who condemned Novartis's AveXis for submitting falsified data to the US FDA.

Elizabeth Warren and Bernie Sanders just slammed the Swiss drug giant Novartis over a new controversy swirling around the world’s most expensive...

"This scandal smacks of the pharmaceutical industry's privilege and greed, and Americans are sick of it," they wrote to the FDA's acting leader.
Isaac Olthoff, 11 months old, will be able to get the gene-therapy treatment Zolgensma under a new, expanded policy from health insurer Aetna.

Dispensed: Insurers will now cover a $2.1 million drug for kids, the pharma industry’s AI ambitions, and a caravan to Canada in search of cheape...

Welcome to Dispensed, our weekly dispatch of healthcare, biotech, and pharma news from Business Insider.
Jackson Schultheis is now eligible for the spinal muscular atrophy treatment Zolgensma after his health insurer changed its policy.

Aetna and Anthem will now pay for more kids with a devastating rare disease to get a $2.1 million drug, reversing earlier denials

Business Insider's reporting highlighted families fighting for access to the treatment, Zolgensma, which is the most expensive drug in the world.

Dispensed: A big week for digital health IPOs, what happens when a $2.1 million drug can’t get to the kids who need it, and what a top health-te...

Welcome to Dispensed, our weekly dispatch of healthcare, biotech, and pharma news from Business Insider.
Jackson Schultheis has been denied a new, $2.1 million treatment for the condition spinal muscular atrophy by health insurer Anthem Blue Cross Blue Shield.

‘Like we were being forced to gamble with our son’s life’: Health insurers won’t pay for a $2.1 million drug for kids, and par...

It's "heartbreaking," one mom said, "because this one person is everything to us. And they're acting like his life doesn't really matter."
Jonathan Lasko, 31, holds the hand of his son Max, age 3.5, who was born with spinal muscular atrophy. A new one-time treatment was just approved for the disease, with a $2.1 million price tag.

The US just approved a $2.1 million treatment for a devastating disease. It’s the most expensive drug in the world.

The treatment, called Zolgensma, should last longer than a typical drug. It also has a much higher price tag.

Dispensed: Venture-backed insurance startup Bright Health’s 2018 results, a dispute between 2 drug giants, and the quest for a male birth contro...

Welcome to Dispensed, Business Insider's weekly newsletter giving you a dose of pharma, biotech, and healthcare news.
Novartis executive Jay Bradner says that the company is developing drugs that could prevent cancer before patients get it — a forward-thinking approach that other drugmakers aren't taking.

A top Novartis executive says the $225 billion drug giant is planning for a ‘doomsday scenario’ in cancer treatment

Pharma giant Novartis is developing drugs that could prevent cancer before patients get it. One big question: how will we pay for them?

A revolutionary drug that could treat a rare and devastating disease is prohibitively expensive. But one state has a plan to pay for its potential $5 ...

A one-time treatment for a devastating rare disease could be paid for with an installment plan in Massachusetts. That could set a roadmap for the US.
A federal antitrust case brought by 45 states alleges that nearly 20 generic drug companies illegally collaborated to jack up prices for their drugs.

A huge lawsuit accuses nearly 20 big drug companies, a billionaire, and 2 brothers-in-law of cozying up to hike drug prices. Here’s the inside s...

Business Insider is the first to report on the unredacted suit, which alleges frequent, close communications among employees of rival companies about how to increase prices.